BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2013953)

  • 1. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
    Moore RD; Kessler H; Richman DD; Flexner C; Chaisson RE
    JAMA; 1991 May; 265(17):2208-11. PubMed ID: 2013953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.
    Pluda JM; Venzon DJ; Tosato G; Lietzau J; Wyvill K; Nelson DL; Jaffe ES; Karp JE; Broder S; Yarchoan R
    J Clin Oncol; 1993 Jun; 11(6):1099-107. PubMed ID: 8099121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(34):591, 597-600. PubMed ID: 1870560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
    Pluda JM; Yarchoan R; Jaffe ES; Feuerstein IM; Solomon D; Steinberg SM; Wyvill KM; Raubitschek A; Katz D; Broder S
    Ann Intern Med; 1990 Aug; 113(4):276-82. PubMed ID: 1973886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.
    Glesby MJ; Moore RD; Chaisson RE
    J Infect Dis; 1993 Nov; 168(5):1264-8. PubMed ID: 8228361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
    Stambuk D; Hawkins D; Gazzard BG
    J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of AIDS-related non-Hodgkin's lymphoma.
    Northfelt DW; Kaplan LD
    Curr Opin Oncol; 1991 Oct; 3(5):872-80. PubMed ID: 1661169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients.
    Mitchell DM; Fleming J; Pinching AJ; Harris JR; Moss FM; Veale D; Shaw RJ
    Am Rev Respir Dis; 1992 Sep; 146(3):745-51. PubMed ID: 1519857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
    Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
    J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-related lymphoma of the oral cavity.
    Colmenero C; Gamallo C; Pintado V; Patron M; Sierra I; Valencia E
    Int J Oral Maxillofac Surg; 1991 Feb; 20(1):2-6. PubMed ID: 2019778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies.
    Campanini A; Marani M; Mastroianni A; Cancellieri C; Vicini C
    Acta Otorhinolaryngol Ital; 2005 Feb; 25(1):30-5. PubMed ID: 16080313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Centers for Disease Control. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy--United States.
    JAMA; 1991 Sep; 266(12):1620-1. PubMed ID: 1886178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.